We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$4.53B
AUM Growth
+$74M
Cap. Flow
-$53.9M
Cap. Flow %
-1.19%
Top 10 Hldgs %
16.99%
Holding
1,686
New
82
Increased
587
Reduced
862
Closed
57

Sector Composition

Rank Sector Weight
1 Technology 15.3%
2 Financials 14.57%
3 Healthcare 12.35%
4 Industrials 9.68%
5 Consumer Discretionary 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIL icon
426
Gildan
GIL
$10.8B
$1.86M 0.04%
48,136
-518
-1% -$19.3K
SF
427
Stifel
SF
$12.6B
$1.86M 0.04%
70,729
-839
-1% -$21.4K
KEYS icon
428
Keysight
KEYS
$57.6B
$1.85M 0.04%
20,632
+413
+2% +$35.1K
EHC icon
429
Encompass Health
EHC
$12.4B
$1.84M 0.04%
36,570
+8,409
+30% +$408K
VAR
430
DELISTED
Varian Medical Systems, Inc.
VAR
$1.84M 0.04%
13,526
+1,107
+9% +$148K
HPQ icon
431
HP
HPQ
$25.8B
$1.84M 0.04%
88,541
-22,397
-20% -$443K
WY icon
432
Weyerhaeuser
WY
$18.3B
$1.84M 0.04%
69,900
-2,897
-4% -$73.6K
AXTA icon
433
Axalta
AXTA
$8.03B
$1.82M 0.04%
61,221
-11,305
-16% -$300K
WRK
434
DELISTED
WestRock Company
WRK
$1.81M 0.04%
49,741
-6,413
-11% -$236K
NTRS icon
435
Northern Trust
NTRS
$33.7B
$1.81M 0.04%
20,107
-871
-4% -$80.2K
CSL icon
436
Carlisle Companies
CSL
$15.2B
$1.8M 0.04%
12,822
-1,128
-8% -$152K
EXPO icon
437
Exponent
EXPO
$3.21B
$1.79M 0.04%
30,674
-2,168
-7% -$123K
IT icon
438
Gartner
IT
$11.7B
$1.79M 0.04%
11,155
-208
-2% -$32.5K
MOH icon
439
Molina Healthcare
MOH
$10B
$1.79M 0.04%
12,510
-747
-6% -$102K
EBS icon
440
Emergent Biosolutions
EBS
$272M
$1.77M 0.04%
+36,713
New +$1.76M
RMD icon
441
ResMed
RMD
$32.4B
$1.77M 0.04%
14,496
+187
+1% +$20.7K
AR icon
442
Antero Resources
AR
$10.7B
$1.77M 0.04%
319,768
-259,859
-45% -$1.87M
IPG
443
DELISTED
Interpublic Group of Companies
IPG
$1.75M 0.04%
77,342
-2,532
-3% -$56.2K
RCL icon
444
Royal Caribbean
RCL
$85.7B
$1.75M 0.04%
14,407
+2,575
+22% +$314K
TRN icon
445
Trinity Industries
TRN
$2.47B
$1.74M 0.04%
83,816
-3,197
-4% -$68K
JAZZ icon
446
Jazz Pharmaceuticals
JAZZ
$16.7B
$1.74M 0.04%
12,203
+161
+1% +$21.6K
ALC icon
447
Alcon
ALC
$33.9B
$1.74M 0.04%
+28,025
New +$1.65M
AMN icon
448
AMN Healthcare
AMN
$1.19B
$1.74M 0.04%
31,975
+2,847
+10% +$144K
CHGG icon
449
Chegg
CHGG
$98.4M
$1.73M 0.04%
44,888
-1,056
-2% -$39.8K
VET icon
450
Vermilion Energy
VET
$1.68B
$1.73M 0.04%
79,572
-24,828
-24% -$579K

Similar funds

Oppenheimer Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Oppenheimer Asset Management held 1,686 positions worth $4.53B, up 1.7% from $4.45B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer Asset Management's Q2 2019 filing shows 82 new, 587 increased, 862 reduced and 57 closed positions. Its largest new stake was Dow Inc: 138,432 shares worth $6.83M. The largest sale was iShares MBS ETF, an estimated $11.6M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer Asset Management's largest Q2 2019 buy was Dow Inc: 138,432 shares worth $6.83M.
  • Oppenheimer Asset Management added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q2 2019, an estimated $12.9M increase.
  • Oppenheimer Asset Management's biggest Q2 2019 reduction was iShares MBS ETF, cutting an estimated $11.6M.
  • Oppenheimer Asset Management fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $9.6M.
  • Oppenheimer Asset Management's ten largest holdings make up 17% of its $4.53B portfolio in Q2 2019.
  • Oppenheimer Asset Management opened 82 new positions and closed 57 in Q2 2019.
  • Oppenheimer Asset Management's portfolio value rose 1.7% quarter-over-quarter to $4.53B.

Based on Oppenheimer Asset Management's 13F filing for Q2 2019, filed 9 Aug 2019.